These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 10626222)
1. 32P-postlabelling with high-performance liquid chromatography for analysis of abundant DNA adducts in human tissues. Yang K; Fang JL; Li D; Chung FL; Hemminki K IARC Sci Publ; 1999; (150):205-17. PubMed ID: 10626222 [TBL] [Abstract][Full Text] [Related]
2. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Wang M; Dhingra K; Hittelman WN; Liehr JG; de Andrade M; Li D Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):705-10. PubMed ID: 8877062 [TBL] [Abstract][Full Text] [Related]
3. Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Li D; Wang M; Dhingra K; Hittelman WN Cancer Res; 1996 Jan; 56(2):287-93. PubMed ID: 8542582 [TBL] [Abstract][Full Text] [Related]
4. Detection of 1, N2-propanodeoxyguanosine adducts as potential endogenous DNA lesions in rodent and human tissues. Nath RG; Ocando JE; Chung FL Cancer Res; 1996 Feb; 56(3):452-6. PubMed ID: 8564951 [TBL] [Abstract][Full Text] [Related]
5. DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. Wang M; Abbruzzese JL; Friess H; Hittelman WN; Evans DB; Abbruzzese MC; Chiao P; Li D Cancer Res; 1998 Jan; 58(1):38-41. PubMed ID: 9426054 [TBL] [Abstract][Full Text] [Related]
6. DNA adducts in normal colonic mucosa from healthy controls and patients with colon polyps and colorectal carcinomas. Jonsson C; Stål P; Sjöqvist U; Akerlund JE; Löfberg R; Möller L Mutagenesis; 2010 Sep; 25(5):499-504. PubMed ID: 20551081 [TBL] [Abstract][Full Text] [Related]
7. Cancer risk assessment for crotonaldehyde and 2-hexenal: an approach. Eder E; Schuler D; Budiawan IARC Sci Publ; 1999; (150):219-32. PubMed ID: 10626223 [TBL] [Abstract][Full Text] [Related]
8. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay. Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535 [TBL] [Abstract][Full Text] [Related]
9. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure. Wohlin P; Zeisig M; Gustafsson JA; Möller L Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995 [TBL] [Abstract][Full Text] [Related]
10. Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. Zhu J; Chang P; Bondy ML; Sahin AA; Singletary SE; Takahashi S; Shirai T; Li D Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):830-7. PubMed ID: 14504191 [TBL] [Abstract][Full Text] [Related]
11. DNA adducts in human breast tissue: association with N-acetyltransferase-2 (NAT2) and NAT1 genotypes. Pfau W; Stone EM; Brockstedt U; Carmichael PL; Marquardt H; Phillips DH Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1019-25. PubMed ID: 9829711 [TBL] [Abstract][Full Text] [Related]
12. A solid-phase extraction/high-performance liquid chromatography-based (32)P-postlabeling method for detection of cyclic 1,N(2)-propanodeoxyguanosine adducts derived from enals. Pan J; Davis W; Trushin N; Amin S; Nath RG; Salem N; Chung FL Anal Biochem; 2006 Jan; 348(1):15-23. PubMed ID: 16289438 [TBL] [Abstract][Full Text] [Related]
13. 1,N2-propanodeoxyguanosine adducts: potential new biomarkers of smoking-induced DNA damage in human oral tissue. Nath RG; Ocando JE; Guttenplan JB; Chung FL Cancer Res; 1998 Feb; 58(4):581-4. PubMed ID: 9485001 [TBL] [Abstract][Full Text] [Related]
14. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination. Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491 [TBL] [Abstract][Full Text] [Related]
15. Detection of 1,N6-etheno-2'-deoxyadenosine and 3,N4-etheno-2'-deoxycytidine occurring endogenously in DNA. Watson WP; Aston JP; Barlow T; Crane AE; Potter D; Brown T IARC Sci Publ; 1999; (150):63-73. PubMed ID: 10626209 [TBL] [Abstract][Full Text] [Related]
17. Role of 1,N2-propanodeoxyguanosine adducts as endogenous DNA lesions in rodents and humans. Chung FL; Zhang L; Ocando JE; Nath RG IARC Sci Publ; 1999; (150):45-54. PubMed ID: 10626207 [TBL] [Abstract][Full Text] [Related]
18. Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen. Shibutani S; Suzuki N; Laxmi YR; Schild LJ; Divi RL; Grollman AP; Poirier MC Cancer Res; 2003 Aug; 63(15):4402-6. PubMed ID: 12907611 [TBL] [Abstract][Full Text] [Related]
19. An improved 32P-postlabeling/high-performance liquid chromatography method for the analysis of the malondialdehye-derived 1, N2-propanodeoxyguanosine DNA adduct in animal and human tissues. Yi P; Sun X; Doerge DR; Fu PP Chem Res Toxicol; 1998 Sep; 11(9):1032-41. PubMed ID: 9760277 [TBL] [Abstract][Full Text] [Related]
20. Carcinogen-DNA adducts in human breast tissue. Perera FP; Estabrook A; Hewer A; Channing K; Rundle A; Mooney LA; Whyatt R; Phillips DH Cancer Epidemiol Biomarkers Prev; 1995; 4(3):233-8. PubMed ID: 7606197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]